Open original FDA record ↗Recall record
- FDA identifier
- Z-1626-2020
- Company in FDA record
- Gentell, Inc
- FDA classification date
- Mar 5, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
During an FDA audit, it was discovered that the product was not properly registered with FDA.
Source facts
- Action
- On February 27, 2020, the firm notified customers by distributing Urgent Medical Device Recall letters. Customers were informed that the products were not properly registered with the FDA, and that the firm is discontinuing the product permanently. Customers were asked to quarantine and return the product. To return product, customers are to complete the response form included with the letter and fax or email it back to the firm. A quality representative will contact customers with a return goods authorization number, provide instruction for the return of the product(s) to Gentell, and arrange for any refund that may be due. The response form should be completed and returned even if customers have no affected stock on hand. Customers with questions should contact Valerie Falkenberg, Monday through Friday, 9:00 AM to 5:00 PM, Eastern Time, 800-840-9041 or vfalkenberg@gentell.com.
- Initiated
- 2020-02-27
- Root cause
- No Marketing Application
- Distribution
- Worldwide distribution US Nationwide distribution in the states of AL, CA, FL, IA, IL, KY, MA, MI, MN, NC, NJ, NY, OH, OK, PA, Puerto Rico, RI, SC, TN, TX, WI and countries of Panama, South Africa, Bahrain, Spain, Mexico, Costa Rica, Romania.
- Recall number
- Z-1626-2020
- Recall status
- Open, Classified
- CDRH record ID
- 179945
- FDA classified
- 2020-03-05
- Recall event number
- 85034